| pubmed-article:6452462 | pubmed:abstractText | A method is described for the quantitative analysis in plasma of Ro 10-9359, an aromatic retinoic acid analogue, ethyl all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate and its major metabolite Ro 10-1670, all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,3,6,8-nonatetraenoic acid. The compounds are extracted from patient plasma with diethyl ether, separated on a reversed-phase column and detected and quantified by their UV absorption. The experimental error is below 9% in the concentration range 42-445 ng/ml. The detection limit is about 10 ng/ml. The method was applied to the analysis of plasma levels in healthy volunteers, receiving 75 mg orally. | lld:pubmed |
